New articles about the science backing our culture’s recently revived appreciation of psychedelics are being published every day. Truly, there is no shortage of information… Read More »A New Understanding: The Science of Psilocybin
Chief Medical Officer Dr. Guy Goodwin clarifies “COMP360 psilocybin therapy was generally well-tolerated” by patients with treatment-resistant depression, despite some adverse reactions from subjects in… Read More »Compass Pathways Releases Promising New Data from Landmark Psilocybin Therapy Trial
“A single dose of psilocybin generated a rapid response that lasted up to 12 weeks,” explains principal investigator Dr. David J. Hellerstein, who was evaluating… Read More »Largest Psilocybin Therapy Trial Ever Conducted Shows Depressive Symptoms Rapidly Reduce